Article Text

other Versions

PDF
Highlights from the literature

Statistics from Altmetric.com

Azithromycin in labour

Two contrasting outcomes for a similar therapy. Tita et al (N Engl J Med 2016;375:1231–41) randomised 2,013 women to receive azithromycin 500 mg intravenously as prophylaxis for caesarean section during labour or after membrane rupture in a multicentre trial in the USA; there was definite benefit for women in terms of lower rates of endometritis and wound infection, but no evident benefit for their babies. On the other hand, Oluwalana et al (Pediatrics 2016;139, February:e20162281) randomised 829 Gambian women to 2 g oral azithromycin or placebo during labour, with a 98% vaginal delivery rate. There was a substantial and highly significant difference in rates of maternal infections in the azithromycin group, and a smaller but still significant difference in the babies. Context is everything.

Breaking bad news in prenatal medicine

Practitioners of both fetal and neonatal medicine commonly find themselves in the same room with a family where a pre-natal problem has been identified. This may mean explaining about the implications of serious or potentially lethal fetal abnormalities, the implications of poor fetal growth, or the likelihood of extremely preterm delivery. …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.